Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > Articles online first > The Journal of Cardiovascular Surgery 2023 Jan 13

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  VASCULAR SECTION 

The Journal of Cardiovascular Surgery 2023 Jan 13

DOI: 10.23736/S0021-9509.22.12535-8

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Intravascular lithotripsy: a powerful tool to treat peripheral artery calcifications

Sébastien VEDANI, Didem HALIGÜR, Silvan JUNGI, Michel J. BOSIERS

Department of Vascular Surgery, University Hospital of Bern, University of Bern, Bern, Switzerland


PDF


Calcification represent one the most important predictors of treatment failure of endovascular therapy for peripheral arterial disease, since it restricts wall expansion and acts as a barrier for drug uptake. It also increases complications after PTA like dissection, perforation, and embolization with poor outcomes. Intravascular lithotripsy (IVL) is a novel approach for the treatment of vascular calcifications with the goal to optimize outcome in patients with PAD and heavy calcifications. This review gives an overview of the currently published articles regarding the use of IVL within the vascular field. In conclusion, IVL is a safe and effective approach in the treatment of highly calcified arteries with excellent results and low rates of related complications, such as embolization, dissection, and perforation. However, it seems to require adjunctive therapies to enhance long-term patency as well as an adequate sizing (1.1:1 ratio). Its use to facilitate access of large-bore devices seems to be valuable by changing vessel compliance and achieving luminal gain. Further studies are nonetheless mandatory.


KEY WORDS: Lithotripsy; Calcification, physiologic; Peripheral arterial disease

top of page